PPARA and malignant colon neoplasm: In addition, using miRNA microarray analyses, Tong et al. demonstrated that miR-506 was overexpressed in hydroxycamptothecin (HCPT)-resistant human colon cancer cells and that miR-506 conferred cancer cells resistance to HCPT by inhibiting PPARα expression [40].